119 related articles for article (PubMed ID: 10371345)
1. Cyclin-D1 expression in human renal-cell carcinoma.
Hedberg Y; Davoodi E; Roos G; Ljungberg B; Landberg G
Int J Cancer; 1999 Jun; 84(3):268-72. PubMed ID: 10371345
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of cyclin D1 in renal cell carcinoma.
Lima MS; Pereira RA; Costa RS; Tucci S; Dantas M; Muglia VF; Ravinal RC; Barros-Silva GE
Int Urol Nephrol; 2014 May; 46(5):905-13. PubMed ID: 24242739
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray.
Hedberg Y; Ljungberg B; Roos G; Landberg G
Br J Cancer; 2003 May; 88(9):1417-23. PubMed ID: 12778072
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D3 protein content in human renal cell carcinoma in relation to cyclin D1 and clinico-pathological parameters.
Hedberg Y; Roos G; Ljungberg B; Landberg G
Acta Oncol; 2002; 41(2):175-81. PubMed ID: 12102163
[TBL] [Abstract][Full Text] [Related]
5. Cyclin E and p27 protein content in human renal cell carcinoma: clinical outcome and associations with cyclin D.
Hedberg Y; Davoodi E; Ljungberg B; Roos G; Landberg G
Int J Cancer; 2002 Dec; 102(6):601-7. PubMed ID: 12448001
[TBL] [Abstract][Full Text] [Related]
6. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
[TBL] [Abstract][Full Text] [Related]
7. Retinoblastoma protein in human renal cell carcinoma in relation to alterations in G1/S regulatory proteins.
Hedberg Y; Ljungberg B; Roos G; Landberg G
Int J Cancer; 2004 Mar; 109(2):189-93. PubMed ID: 14750168
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 and p57 expression in relation to clinicopathological characteristics and overall survival in patients with renal cell carcinoma.
Latic D; Pejic S; Savic S; Loncar Z; M Nikolic I; Nikolic G; Pavlovic I; Radojevic-Skodric S
J BUON; 2019; 24(1):301-309. PubMed ID: 30941985
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation.
Barroca H; Castedo S; Vieira J; Teixeira M; Müller-Höcker J
Pathol Res Pract; 2009; 205(7):466-72. PubMed ID: 19246164
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
11. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
Allory Y; Matsuoka Y; Bazille C; Christensen EI; Ronco P; Debiec H
Clin Cancer Res; 2005 Feb; 11(3):1190-7. PubMed ID: 15709188
[TBL] [Abstract][Full Text] [Related]
12. Clear cell papillary renal cell carcinoma is an indolent and low-grade neoplasm with overexpression of cyclin-D1.
Leroy X; Camparo P; Gnemmi V; Aubert S; Flamand V; Roupret M; Fantoni JC; Comperat E
Histopathology; 2014 Jun; 64(7):1032-6. PubMed ID: 24382138
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study.
Lin BT; Brynes RK; Gelb AB; McCourty A; Amin MB; Medeiros LJ
Mod Pathol; 1998 Nov; 11(11):1075-81. PubMed ID: 9831205
[TBL] [Abstract][Full Text] [Related]
14. p53 expression in correlation to clinical outcome in patients with renal cell carcinoma.
Ljungberg B; Bozoky B; Kovacs G; Stattin P; Farrelly E; Nylander K; Landberg G
Scand J Urol Nephrol; 2001 Feb; 35(1):15-20. PubMed ID: 11291681
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome.
Mishina T; Dosaka-Akita H; Kinoshita I; Hommura F; Morikawa T; Katoh H; Kawakami Y
Br J Cancer; 1999 Jun; 80(8):1289-95. PubMed ID: 10376986
[TBL] [Abstract][Full Text] [Related]
17. p16INK4a expression and clinicopathologic parameters in renal cell carcinoma.
Ikuerowo SO; Kuczyk MA; von Wasielewski R; Shittu OB; Jonas U; Machtens S; Serth J
Eur Urol; 2007 Mar; 51(3):732-7; discussion 738. PubMed ID: 16949731
[TBL] [Abstract][Full Text] [Related]
18. Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma.
Migita T; Oda Y; Naito S; Tsuneyoshi M
Cancer; 2002 Feb; 94(4):973-9. PubMed ID: 11920465
[TBL] [Abstract][Full Text] [Related]
19. Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique.
Langner C; von Wasielewski R; Ratschek M; Rehak P; Zigeuner R
Virchows Arch; 2004 Dec; 445(6):631-6. PubMed ID: 15517366
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis.
Bartkova J; Lukas J; Strauss M; Bartek J
Oncogene; 1995 Feb; 10(4):775-8. PubMed ID: 7862456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
